In-Hospital and 1-Year Clinical Results from the French Registry Using Polymer-Free Sirolimus-Eluting Stents in Acute Coronary Syndrome and Stable Coronary Artery Disease

Table 1

Patient demographic data, lesion morphologies, and procedural details of Coroflex® ISAR NEO (B. Braun).

Patient demographics
Variable	All patients	Stable CAD	ACS	value
Number of patients	1456	895	561	—
			205 STEMI
Number of lesions	2079	1302	777	—
Number of DES	2110	1323	787	—
DES per patient	1.40 ± 0.66	1.41 ± 0.67	1.38 ± 0.66	0.461
Age (years)	68.2 ± 11.3	68.4 ± 10.3	67.9 ± 12.9	0.384
Male gender	1080 (74.2%)	693 (77.4%)	387 (69.0%)	<0.001
Diabetes
Insulin-dependent	103 (7.1%)	77 (8.6%)	26 (4.6%)	0.003
Non-insulin-dependent	280 (19.2%)	182 (20.3%)	98 (17.5%)
Hypertension	902 (62.0%)	571 (63.8%)	331 (59.0%)	0.067
History of smoking	437 (30.0%)	254 (28.4%)	183 (32.6%)	0.086
Renal insufficiency
Stage 1 to 3a GFR > 60 ml/min/1.73 m^2	1401 (96.3%)	864 (96.5%)	537 (95.7%)	0.760
Stage 3b to 5 GFR < 60 ml/min/1.73 m^2	55 (3.7%)	31 (3.5%)	24 (4.3%)
Dialysis dependence	20 (1.4%)	13 (1.5%)	7 (1.2%)	0.744